A Study of Glyceryl Tri-(4-phenylbutyrate) Administered Orally as a Single Dose, and Twice Daily for Seven Consecutive Days to Subjects With Hepatic Impairment With Cirrhosis and to a Control Group

Clinical Trial ID NCT00986895

Rank	Title	Journal	Year	PubWeight™‹?›
1	Pharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosis.	Hepatology	2010	1.48
2	Orphan drug incentives in the pharmacogenomic context: policy responses in the USA and Canada.	J Law Biosci	2016	0.79